ATE165005T1 - Dextrinsulfate als anti hiv-1 wirkstoffe und diese enthaltende zubereitungen - Google Patents

Dextrinsulfate als anti hiv-1 wirkstoffe und diese enthaltende zubereitungen

Info

Publication number: ATE165005T1
Authority: AT; Austria
Prior art keywords: pct; agent; dextrine; sulphates; active ingredients
Prior art date: 1990-09-25

Application number

AT91916848T

Other languages

English (en)

Inventor

Donald Selwyn Davies

Original Assignee

Ml Lab Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-09-25

Filing date

1991-09-23

Publication date

1998-05-15

1991-09-23 Application filed by Ml Lab Plc filed Critical Ml Lab Plc

1998-05-15 Application granted granted Critical

1998-05-15 Publication of ATE165005T1 publication Critical patent/ATE165005T1/de

Links

229920001353 Dextrin Polymers 0.000 title abstract 4
241000713772 Human immunodeficiency virus 1 Species 0.000 title abstract 3
-1 DEXTRINE SULPHATES Chemical class 0.000 title 1
239000004480 active ingredient Substances 0.000 title 1
238000002360 preparation method Methods 0.000 title 1
QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 abstract 4
239000003795 chemical substances by application Substances 0.000 abstract 4
239000004375 Dextrin Substances 0.000 abstract 3
235000019425 dextrin Nutrition 0.000 abstract 3
229910021653 sulphate ion Inorganic materials 0.000 abstract 3
241000700605 Viruses Species 0.000 abstract 2
230000036436 anti-hiv Effects 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 abstract 1
238000006467 substitution reaction Methods 0.000 abstract 1
230000001988 toxicity Effects 0.000 abstract 1
231100000419 toxicity Toxicity 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B31/00—Preparation of derivatives of starch
- C08B31/02—Esters
- C08B31/06—Esters of inorganic acids
- C08B31/063—Starch sulfates

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Molecular Biology (AREA)
Virology (AREA)
General Chemical & Material Sciences (AREA)
Materials Engineering (AREA)
Oncology (AREA)
Polymers & Plastics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Communicable Diseases (AREA)
Epidemiology (AREA)
Inorganic Chemistry (AREA)
Engineering & Computer Science (AREA)
Biochemistry (AREA)
Tropical Medicine & Parasitology (AREA)
AIDS & HIV (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

AT91916848T 1990-09-25 1991-09-23 Dextrinsulfate als anti hiv-1 wirkstoffe und diese enthaltende zubereitungen ATE165005T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB909020861A GB9020861D0 (en)	1990-09-25	1990-09-25	Pharmaceutical compositions

Publications (1)

Publication Number	Publication Date
ATE165005T1 true ATE165005T1 (de)	1998-05-15

Family

ID=10682722

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT91916848T ATE165005T1 (de)	1990-09-25	1991-09-23	Dextrinsulfate als anti hiv-1 wirkstoffe und diese enthaltende zubereitungen

Country Status (15)

Country	Link
US (2)	US5439892A (de)
EP (1)	EP0550532B1 (de)
JP (1)	JP3281373B2 (de)
AT (1)	ATE165005T1 (de)
AU (1)	AU649731B2 (de)
CA (1)	CA2092094C (de)
DE (1)	DE69129272T2 (de)
DK (1)	DK0550532T3 (de)
ES (1)	ES2113888T3 (de)
GB (1)	GB9020861D0 (de)
IE (1)	IE913340A1 (de)
NZ (1)	NZ239908A (de)
PT (1)	PT99057B (de)
WO (1)	WO1992004904A1 (de)
ZA (1)	ZA917597B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9625193D0 (en) *	1996-12-04	1997-01-22	Ml Lab Plc	Treatment of highly vascular tumours
DE69833487T9 (de)	1997-06-12	2007-03-01	Innovata Plc, Ruddington	Polymer-wirkstoff-konjugate zur behandlung von krebs
US6077503A (en) *	1997-07-30	2000-06-20	Amway Corporation	Skin whitener composition containing mercaptodextran
US6821958B1 (en)	2001-03-06	2004-11-23	Roger K. Hershline	Antiviral composition
US20050209189A1 (en) *	2001-03-06	2005-09-22	Roger Hershline	Antiviral composition
CA2471300A1 (en) *	2001-12-24	2003-07-10	Alan Chapman	Composition comprising dextrinsulfate for the treatment of sexual transmitted diseases (std)
US20040009953A1 (en) *	2002-01-10	2004-01-15	Comper Wayne D.	Antimicrobial charged polymers that exhibit resistance to lysosomal degradation during kidney filtration and renal passage, compositions and method of use thereof
US20030181416A1 (en) *	2002-01-10	2003-09-25	Comper Wayne D.	Antimicrobial charged polymers that exhibit resistance to lysosomal degradation during kidney filtration and renal passage, compositions and method of use thereof
US20060234977A1 (en) *	2003-01-23	2006-10-19	Gina Wenham	Antiviral compostion comprising a sulphated glucose polymer and a bacteriostatic agent
WO2005004882A1 (en) *	2003-07-09	2005-01-20	Monash University	Antiviral charged polymers that exhibit resistance to lysosomal degradation during kidney filtration and renal passage, compositions and methods of use thereof
US7285582B2 (en) *	2004-12-30	2007-10-23	Conocophillips Company	Modified latex drag reducer and processes therefor and therewith
US20070225191A1 (en) *	2006-03-27	2007-09-27	The Procter & Gamble Company	Methods for modifying bioplymers in ionic liquids

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2967178A (en) *	1957-12-06	1961-01-03	Corn Products Co	Method of producing gelling starch of high clarity
US3017407A (en) *	1958-08-18	1962-01-16	Riker Laboratories Inc	Process for producing polysulfuric acid esters of polysaccharides
US3070595A (en) *	1960-10-28	1962-12-25	Riker Laboratories Inc	Process for producing polysulfuric acid esters of polysaccharides
DE3601136A1 (de) *	1986-01-16	1987-07-23	Max Planck Gesellschaft	Hemmstoffe der reversen transkriptase fuer prophylaxe und therapie von retrovirus-infektionen in saeugetieren
EP0240098A3 (de) *	1986-04-04	1989-05-10	Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo	Oligo und Polysaccharide zur Behandlung von Krankheiten verursacht durch Retroviren
SE453394B (sv) *	1986-07-07	1988-02-01	Pharmacia Ab	Forfarande for framstellning av sulfaterade polysackarider genom anvendning av ett reducerande medel for sulfateringsreaktionen
WO1989003684A1 (fr) *	1987-10-30	1989-05-05	Chugai Seiyaku Kabushiki Kaisha	Agent anti-vih
GB9001687D0 (en) *	1990-01-25	1990-03-28	Ml Lab Plc	Treatment of poisoning and composition for use therein
US5221669A (en) *	1991-04-19	1993-06-22	The United States Of America As Represented By The Department Of Health And Human Services	Antiviral compositions containing α-cyclodextrin sulfates alone and in combination with other known antiviral agents and glucocorticoids and methods of treating viral infections

1990
- 1990-09-25 GB GB909020861A patent/GB9020861D0/en active Pending
1991
- 1991-09-23 DE DE69129272T patent/DE69129272T2/de not_active Expired - Fee Related
- 1991-09-23 WO PCT/GB1991/001628 patent/WO1992004904A1/en not_active Ceased
- 1991-09-23 DK DK91916848T patent/DK0550532T3/da active
- 1991-09-23 AU AU86145/91A patent/AU649731B2/en not_active Ceased
- 1991-09-23 AT AT91916848T patent/ATE165005T1/de not_active IP Right Cessation
- 1991-09-23 US US08/030,227 patent/US5439892A/en not_active Expired - Fee Related
- 1991-09-23 JP JP51528291A patent/JP3281373B2/ja not_active Expired - Fee Related
- 1991-09-23 EP EP91916848A patent/EP0550532B1/de not_active Expired - Lifetime
- 1991-09-23 NZ NZ239908A patent/NZ239908A/xx not_active IP Right Cessation
- 1991-09-23 ES ES91916848T patent/ES2113888T3/es not_active Expired - Lifetime
- 1991-09-23 CA CA002092094A patent/CA2092094C/en not_active Expired - Fee Related
- 1991-09-24 ZA ZA917597A patent/ZA917597B/xx unknown
- 1991-09-24 IE IE334091A patent/IE913340A1/en not_active IP Right Cessation
- 1991-09-25 PT PT99057A patent/PT99057B/pt not_active IP Right Cessation
1995
- 1995-03-24 US US08/410,067 patent/US6015799A/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
NZ239908A (en)	1993-03-26
GB9020861D0 (en)	1990-11-07
EP0550532B1 (de)	1998-04-15
JPH06503305A (ja)	1994-04-14
CA2092094A1 (en)	1992-03-26
JP3281373B2 (ja)	2002-05-13
AU649731B2 (en)	1994-06-02
EP0550532A1 (de)	1993-07-14
DK0550532T3 (da)	1999-03-08
CA2092094C (en)	2004-08-10
ES2113888T3 (es)	1998-05-16
IE913340A1 (en)	1992-02-25
PT99057B (pt)	1999-02-26
DE69129272T2 (de)	1998-11-12
US5439892A (en)	1995-08-08
US6015799A (en)	2000-01-18
DE69129272D1 (de)	1998-05-20
WO1992004904A1 (en)	1992-04-02
PT99057A (pt)	1992-08-31
ZA917597B (en)	1992-05-27
AU8614591A (en)	1992-04-15

Legal Events

Date	Code	Title	Description
1999-01-15	UEP	Publication of translation of european patent specification
2006-06-15	REN	Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
NO952321D0 (no)	1995-06-13	Polypeptid, samt anti-HIV-preparat fremstilt fra dette
ATE185548T1 (de)	1999-10-15	Verwendung von n-arylmethylen ethylendiamintriacetate, n-arylmethylen iminodiacetat oder n,n'-diarylmethylen ethylendiamindiacetat gegen oxidativen stress
ATE229524T1 (de)	2002-12-15	Distamycin a analoga als antitumor- oder antivirale wirkstoffe
ES2111925T3 (es)	1998-03-16	Piridinas herbicidas sustituidas con heterociclos.
DE69129272D1 (de)	1998-05-20	Dextrinsulfate als anti hiv-1 wirkstoffe und diese enthaltende zubereitungen
DE69019533D1 (de)	1995-06-22	Behandlung von hiv-infizierungen und nützliche verbindungen dafür.
ES2125976T3 (es)	1999-03-16	Otros derivados de indol con accion antiviral.
ES2124307T3 (es)	1999-02-01	Derivados de 3-hidroxipiridin-4-ona como agentes de quelacion.
GR3035014T3 (en)	2001-03-30	N-(3-amino-2-hydroxybutyl)sulphonamide derivatives as hiv protease inhibitors
BR9711647A (pt)	2000-06-06	Novos derivados de ácido dicafeoilquìmico, seu uso, composições com os mesmos e métodos de tratamento usando-os.
ES2132383T3 (es)	1999-08-16	Inhibidores de proteasa hiv.
DK0561846T3 (da)	1995-08-21	4,5-dihydroxy- og 4,5,8-trihydroxy-9,10-dihydro-9,10-dioxo-2-anthracencarboxylsyre-dicarbonater og -urethaner med terapeutisk virkning
DE69403063D1 (de)	1997-06-12	Gegen viren wirksame naphtochinon-verbindungen, zusammensetzungen und deren verwendungen
MC1930A1 (fr)	1989-05-19	Produit antiviral
PT96849A (pt)	1991-10-31	Processo de preparacao de novos derivados da beta-fenil-iso-serina e de beta-fenil-iso-serina-(2r,2s)
NO179009C (no)	1996-07-17	Analogifremgangsmåte for fremstilling av salter av L-alfa-glyserofosforyl-D-myo-inositol
DK0632717T3 (da)	1999-02-22	Middel til anvendelse som et anti-irritationsmiddel
DE59406568D1 (de)	1998-09-03	Cephalostatin-analoga und ihre verwendung als antitumormittel
DE59408645D1 (de)	1999-09-23	Lactulose-pastillen
UA23368A (uk)	1998-08-31	Використання (1,1-діоксотіолан-3-іл) диктіокарбамату калію як антимікробного засобу